Cormorant Asset Management, LP Green Light Biosciences Holdings, Pbc Transaction History

Cormorant Asset Management, LP

  • $1.74 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$1.03 - $2.0 $1.11 Million - $2.15 Million
-1,072,901 Reduced 10.46%
9,188,659 $10.8 Million
Q3 2022

Nov 14, 2022
BUY
$0.42 - $3.92 $1.39 Million - $12.9 Million
3,301,020 Added 47.42%
10,261,560 $23.8 Million
Q2 2022

Aug 15, 2022
BUY
N/A
250,000 Added 3.73%
6,960,540 $15.2 Million
Q1 2022

May 16, 2022
BUY
N/A
6,710,540 New
6,710,540 $62 Million

Others Institutions Holding GRNA

# of Institutions
1
Shares Held
51.5K
Call Options Held
0
Put Options Held
0
View Full List

About GreenLight Biosciences Holdings, PBC

GRNA Quotes by TradingView
  • Ticker GRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 151,460,000
  • Description
  • GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in...
More about GRNA
Track This Portfolio

Track Cormorant Asset Management, LP Portfolio

Follow Cormorant Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email